Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Daré Bioscience On Prowl To Fill Gaps In Women's Sexual Health

Mar 02 2018

• By Emily Hayes

Related Content

Valeant Returns $1bn Female Libido Drug For Free

Nov 07 2017

A New Dawn For Female Sex Dysfunction Drugs? FDA Meeting Cheers Sponsors

Dec 17 2014

Cerulean Shifts From Ovarian Cancer To Contraceptives In Reverse Merger With Daré

Mar 24 2017

Sprout's Flibanserin Gets Reluctant Nod From FDA Panel, But REMS Needed

Jun 05 2015

FDA Adds New Co-Primary Endpoint For Female Sexual Desire Drugs

Oct 27 2016

Related Companies

Daré Bioscience, Inc.

Merck & Co., Inc.

Strategic Science & Technologies LLC

Pfizer Inc.

Bausch Health Companies Inc.

Bayer AG

Sprout Pharmaceuticals, Inc.

Additional Topics

Business Strategies Financing Deals Companies Commercial Gynecology & Urology BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window